Contact Us marketing@medicilon.com
Medicilon Logo
|
search icon search icon 中 contact icon menu icon
Medicilon Logo
|
search icon close search icon 中 contact icon menu icon
ABOUT
Company Profile
Corporate Culture
Management Team
Company History
Message from the CEO
Honors and Awards
Over 20 years of experience in R&D
Learn more
01 Drug Discovery
Chemistry Research
Biology Research
Early Pharmacokinetics
02 Pharmaceutical Research
Intermediates
Active Pharmaceutical Ingredients
Pharmaceutical preparation
Analytical Method Development and Quality Control
CMC Filings
Analytical Testing Center
03 Preclinical Research
Pharmacology & Pharmacodynamics
Drug Safety Evaluation
DMPK
Bioanalysis
IND Filings
01 One-stop Integrated Services
Liposome Drug Development
Drug Discovery
Pharmaceutical Research
Preclinical Research
Botanical Drug Preclinical R&D
02 Innovative Drug Services
ADC
PROTAC
mRNA Vaccine
Cellular Immunotherapies
Nucleic Acid Drug
Peptide Drug Conjugate (PDC)
Antibody
03 Key Technical Services for Drug R&D
Cytokine and Biomarker Detection
Metabolite Identification (MetID)
Drug Forming Research
Flow Cytometry Technology
SEND Format Conversion
Flow Sorting
NanoString nCounter Detection
Routes of Drug Administration
04 Drug Efficacy Evaluation for Common Diseases
IO Pharmacodynamic Model
Inflammatory and Immune Diseases
Rodent Cerebrovascular Disease
05 Advanced Preparation R&D
Inhalation drug
Ophthalmic drug
Skin Topical Preparation
06 Targeted Drugs R&D Services
STAT3-targeted Drugs R&D Service
GLP-1 New Drug R&D Service
KRAS-targeted Drugs R&D Service
CAREERS
Talent Development
Campus Recruitment
Recruitment
Campus Recruitment
Campus Recruitment
Recruitment
Recruitment
News
Medicilon Events
Featured Stories
Market Events
Videos
A.C.E.
2024-07-22Medicilon Events
The Shanghai Overseas Returned Scholars Association invites the Dutch PhD delegation to visit Medicilon, exploring paths for innovative development together
On July 4th, the Shanghai Overseas Returned Scholars Association invited the Dutch PhD delegation to visit the Chuansha campus of Shanghai Medicilon Inc. (Medicilon) and held discussions with Medicilon's Founder and CEO, Chunlin Chen, among others.
Learn more
2024-07-22Medicilon Events
5th consecutive win! Medicilon once again made the list of "Top 20 Chinese R&D CRO Enterprises in 2024"
Medicilon stood out among hundreds of pharmaceutical enterprises and was honored with the "Top 20 Chinese R&D CRO Enterprises in 2024" award.
Learn more
INVESTORS
Stock Information
Investment Contact
Medicilon 688202
RMB

As of Beijing time The data is from a third-party organization and is only for reference.

For actual information, please refer to：www.eastmoney.com

CLIENT CENTER
Intellectual Property Protection
Clients Testimonials
Downloads
Partnerships
Medicilon Support
Newsletters
U.S.

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(626)986-9880

UK

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954

Email: marketing@medicilon.com

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Close

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3

Shanghai Public Network Security File No. 31011502018888 | Website Map

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3
Shanghai Public Network Security File No. 31011502018888|Website Map
关闭
中
Message
Contact Us
Close Button
Back To Top
Online Message×
Click switch
Close Button
News and Events
Medicilon Events Featured Stories Market Events Videos A.C.E.
HomenewsFeatured Stories

Featured Stories

Hot information：
Top 10 Global CDMO Enterprises| The Meaning of IND, NDA and ANDA| Top 10 Global Clinical Research Organizations in 2021
Sep 08,2016
Gene Therapy for Sickle Cell Aces Vital Preclinical Test
    Sickle-cell disease falls into an intriguing scientific paradigm—it is very well studied from multiple scientific angles and most of the molecular mechanisms associated with the disease have been elucidated. However, treatments for the disease have been lacking, as there are very few ways to combat the genetic disorder, without rectifying the DNA mutation that causesRead more
More
Sep 08,2016
Medicilon's Lead Optimization in Drug Discovery
Medicilon's medicinal chemistry involves the application of a number of specialized disciplinary approaches all focused on the ultimate goal of drug discovery.  Drug target identification and validation, rational (target-based) drug design, structural biology, computational-based drug design, methods development (chemical, biochemical and computational), and "Hit-to-lead” development are all aspects of medicinal chemistry.  The techniques and approachesRead more
More
Medicilon's Lead Optimization in Drug Discovery
Sep 07,2016
Flesh Eating Bacteria Vaccine Could Be around the Corner
    Few things will conjure up innate fears more than tiny drug-resistant microorganisms steadily feasting on human tissue, with amputation often being the only recourse for survival. The bacteria that cause necrotizing fasciitis, or "flesh-eating disease”—group A Streptococcus (group A Strep)—is highly infectious and leads to more than 500,000 deaths per year.     Now, biochemists at theRead more
More
Flesh Eating Bacteria Vaccine Could Be around the Corner
Sep 07,2016
Novel Approaches Target Esophageal Cancer
    Researchers say they have discovered that esophageal cancer can be classified into three different subtypes, paving the way for testing targeted treatments tailored to patients' disease for the first time.     Their study ("Mutational Signatures in Esophageal Adenocarcinoma Reveal Etiologically Distinct Subgroups with Therapeutic Relevance”), published in Nature Genetics, could help find drugs that target specific weaknesses inRead more
More
Novel Approaches Target Esophageal Cancer
Sep 07,2016
Preclinical Drug Safety Ealuation and Drug Safety Testing
The preclinical services that Medicilon offers focus on preclinical pharmacokinetic and drug safety assessment (evaluation) for foreign and domestic clients.     Preclinical Drug Safety Testing : In vitro and in vivo testing to determine if the drug is safe enough for human testing. OUR SERVICES: Single dose toxicity test (rodent and non-rodent) Repeated dose toxicityRead more
More
Preclinical Drug Safety Ealuation and Drug Safety Testing
Sep 06,2016
New Technique Improves Analysis of Mitochondrial Dysfunction
    Researchers at the Whitehead Institute say they have developed a method to isolate quickly and systematically measure metabolite concentrations within mitochondria.  Prior attempts at such measurements have yielded unreliable results, either by taking too long to isolate mitochondria or by contaminating mitochondrial metabolites with contents from other cellular components, according to the scientists.       "TheRead more
More
New Technique Improves Analysis of Mitochondrial Dysfunction
Sep 06,2016
That Old Cell Line Just Are Not What It Used to Be
    The use of in vitro-cultured cells within the life sciences is an indispensable tool for a variety of fundamental assays. Yet periodically, cell lines need to be analyzed genetically to make certain that they are not only still representative of the cells from which they were derived—as cultured cells can drift genetically over time—but moreRead more
More
That Old Cell Line Just Are Not What It Used to Be
Sep 05,2016
War on Cancer May Shift to Containment Strategy
The war on cancer may become a cold war, now that a new drug-delivery system has shown that it is possible to combine careful targeting with small, frequent dosing. With such a system, it may be possible to avoid the usual rollback approach, the administration of "maximum tolerable doses” of chemotherapeutic drugs. Because all-out hostilitiesRead more
More
War on Cancer May Shift to Containment Strategy
Sep 05,2016
Cancer and Unstable Genomes Linked to Junk DNA Changes
    Researchers have long known that all humans are 99.9% identical, genetically speaking. But that tiny 0.1% variation has big consequences, influencing the color of your eyes, the span of your hips, and your risk of getting sick.     Although variants are scattered throughout the genome, scientists have largely ignored the stretches of repetitive genetic code onceRead more
More
Cancer and Unstable Genomes Linked to Junk DNA Changes
Sep 02,2016
Vitamin C May Boost to Help Treat Leukemia
Interestingly, a pilot clinical trial based on this work is currently ongoing in adult patients with myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) at Rigshospitalet in Copenhagen, Denmark. This trial combines a similar drug called azacitidine—the standard of care therapy—with vitamin C.
More
Vitamin C May Boost to Help Treat Leukemia
Stock Code
688202

Global

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(626)986-9880(U.S.)

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954 (Europe)

Email: marketing@medicilon.com

  

Address: 5th Floor, 62, Banpodae-ro 4-gil, Seocho-gu, Seoul, 06719 South Korea

Tel: +82 70-8269-5849

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Facebook icon
Twitter icon
Linkedin icon
Youtube icon
© 2023 Shanghai Medicilon Inc. All rights reserved All Rights Reserved Privacy Policy
Website Map
-->